Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119147) titled 'Clinical Research of 18F/68Ga-SMIC-1501W PET in CXCR4-Overexpressing Diseases' on Feb. 24.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
CXCR4-overexpressing neoplastic diseases encompass hematological malignancies, breast cancer, ovarian cancer, among others, as well as non-neoplastic lesions primarily comprising primary aldosteronism, aldosterone-producing adenomas, myocardial infarction, and inflammatory diseases.
Intervention:
Gold Standard:For neoplastic diseases, the diagnostic standard was pathology. For non-neopl...